Partha Pratim Manna (P P Manna)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Topics

Trypanosoma Cruzi

Diffuse Large B Cell Lymphoma

Top Venues

Dalton transactions (Cambridge, England : 2003)

Molecular pharmaceutics

Medical oncology (Northwood, London, England)

ACS applied bio materials

This page only lists publications with an associated author ORCID identifier.

Publications

Debapriya RoyMahapatra, Ranjeet Singh, Ugir Hossain Sk, Partha Pratim Manna
Engineered Artesunate-Naphthalimide Hybrid Dual Drug for Synergistic Multimodal Therapy against Experimental Murine Lymphoma. Molecular pharmaceutics (2024)
Ranjeet Singh, Prateek Srivastava, Partha Pratim Manna
Evaluation of regulatory T-cells in cancer immunotherapy: therapeutic relevance of immune checkpoint inhibition. Medical oncology (Northwood, London, England) 41 (2) (2024)
Anupam Singh, Kunal Shiv, Ranjeet Singh, Manoj Kumar Bharty, Partha Pratim Manna, Lal Bahadur Prasad
Correction: Antiproliferative activity of Ni(II), Cu(II), and Zn(II) complexes of dithiocarbamate: synthesis, structural characterization, and thermal studies. Dalton transactions (Cambridge, England : 2003) 53 (7) (2024)
Anupam Singh, Kunal Shiv, Ranjeet Singh, Manoj Kumar Bharty, Partha Pratim Manna, Lal Bahadur Prasad
Antiproliferative activity of Fe(II), Co(II), Ni(II), Cu(II), and Zn(II) complexes of dithiocarbamate: synthesis, structural characterization, and thermal studies. Dalton transactions (Cambridge, England : 2003) 53 (3) (2024)
Debapriya RoyMahapatra, Ranjeet Singh, Ugir Hossain Sk, Partha Pratim Manna
Engineered Artesunate-Naphthalimide Hybrid Dual Drug for Synergistic Multimodal Therapy against Experimental Murine Lymphoma. Molecular pharmaceutics 21 (3) (2024)
Anupam Singh, Kunal Shiv, Ranjeet Singh, Manoj Kumar Bharty, Partha Pratim Manna, Lal Bahadur Prasad
Antiproliferative activity of Fe(II), Co(II), Ni(II), Cu(II), and Zn(II) complexes of dithiocarbamate: synthesis, structural characterization, and thermal studies. Dalton transactions (Cambridge, England : 2003) 53 (3) (2024)
Ranjeet Singh, Prateek Srivastava, Partha Pratim Manna
Evaluation of regulatory T-cells in cancer immunotherapy: therapeutic relevance of immune checkpoint inhibition. Medical oncology (Northwood, London, England) 41 (2) (2024)
Ranjeet Singh, Prateek Srivastava, Partha Pratim Manna
Evaluation of regulatory T-cells in cancer immunotherapy: therapeutic relevance of immune checkpoint inhibition. Medical oncology (Northwood, London, England) 41 (2) (2024)
Anupam Singh, Kunal Shiv, Ranjeet Singh, Manoj Kumar Bharty, Partha Pratim Manna, Lal Bahadur Prasad
Correction: Antiproliferative activity of Ni(II), Cu(II), and Zn(II) complexes of dithiocarbamate: synthesis, structural characterization, and thermal studies. Dalton transactions (Cambridge, England : 2003) (2024)
Anupam Singh, Kunal Shiv, Ranjeet Singh, Manoj Kumar Bharty, Partha Pratim Manna, Lal Bahadur Prasad
Antiproliferative activity of Fe(II), Co(II), Ni(II), Cu(II), and Zn(II) complexes of dithiocarbamate: synthesis, structural characterization, and thermal studies. Dalton transactions (Cambridge, England : 2003) 53 (3) (2024)
Debapriya RoyMahapatra, Ranjeet Singh, Ugir Hossain Sk, Partha Pratim Manna
Engineered Artesunate-Naphthalimide Hybrid Dual Drug for Synergistic Multimodal Therapy against Experimental Murine Lymphoma. Molecular pharmaceutics 21 (3) (2024)
Ranjeet Singh, Mohammad Kashif, Prateek Srivastava, Partha Pratim Manna
Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host. Pathogens (Basel, Switzerland) 12 (5) (2023)
Anupam Singh, Kunal Shiv, Ranjeet Singh, Manoj Kumar Bharty, Partha Pratim Manna, Lal Bahadur Prasad
Antiproliferative activity of Fe(II), Co(II), Ni(II), Cu(II), and Zn(II) complexes of dithiocarbamate: synthesis, structural characterization, and thermal studies. Dalton transactions (Cambridge, England : 2003) (2023)
Sourov Mondal, Archana Kumari, Kheyanath Mitra, Abhineet Verma, Satyen Saha, Biswajit Maiti, Ranjeet Singh, Partha Pratim Manna, Pralay Maiti, Hironobu Watanabe, Masami Kamigaito, Biswajit Ray
Biocompatible thermoresponsive N -isopropyl- N -(3-(isopropylamino)-3-oxopropyl)acrylamide-based random copolymer: synthesis and studies of its composition dependent properties and anticancer drug delivery efficiency. Journal of materials chemistry. B 10 (41) (2022)
Mohammad Kashif, Sumit Kumar Hira, Partha Pratim Manna
Immunoinformatics based design and prediction of proteome-wide killer cell epitopes of Leishmania donovani: Potential application in vaccine development. Journal of biomolecular structure & dynamics (2021)
R Chaurasia, Shivendra Kumar Pandey, Devesh Kumar Singh, Manoj Kumar Bharty, Vellaichamy Ganesan, Sumit Kumar Hira, Partha Pratim Manna, A Bharti, Raymond John Butcher
Antiproliferative activity and electrochemical oxygen evolution by Ni(II) complexes of N'-(aroyl)-hydrazine carbodithioates. Dalton transactions (Cambridge, England : 2003) 50 (40) (2021)
Prateek Srivastava, Ankush Paladhi, Ranjeet Singh, Divesh Narayan Srivastava, Ram Adhar Singh, Sumit Kumar Hira, Partha Pratim Manna
Targeting PD-1 in CD8+ T Cells with a Biomimetic Bilirubin-5-fluoro-2-deoxyuridine-Bovine Serum Albumin Nanoconstruct for Effective Chemotherapy against Experimental Lymphoma. Molecular pharmaceutics 18 (5) (2021)
Ugir Hossain Sk, Sumit Kumar Hira, Abhinandan Rej, Debapriya RoyMahapatra, Partha Pratim Manna
Development of a PAMAM Dendrimer for Sustained Release of Temozolomide against Experimental Murine Lymphoma: Assessment of Therapeutic Efficacy. ACS applied bio materials 4 (3) (2021)
Mohammad Kashif, Ankush Paladhi, Ranjeet Singh, Sankar Bhattacharyya, Sumit Kumar Hira, Partha Pratim Manna
Leishmanicidal Activity of an In Silico-Screened Novel Inhibitor against Ascorbate Peroxidase of Leishmania donovani. Antimicrobial agents and chemotherapy 64 (7) (2020)
Prateek Srivastava, Sumit Kumar Hira, Amod Sharma, Mohammad Kashif, Prashant Srivastava, Divesh Narayan Srivastava, Ram Adhar Singh, Partha Pratim Manna
Telomerase Responsive Delivery of Doxorubicin from Mesoporous Silica Nanoparticles in Multiple Malignancies: Therapeutic Efficacies against Experimental Aggressive Murine Lymphoma. Bioconjugate chemistry 29 (6) (2018)
Prateek Srivastava, Sumit Kumar Hira, Divesh Narayan Srivastava, Vivek Kumar Singh, Uttam Gupta, Ranjeet Singh, Ram Adhar Singh, Partha Pratim Manna
ATP-Decorated Mesoporous Silica for Biomineralization of Calcium Carbonate and P2 Purinergic Receptor-Mediated Antitumor Activity against Aggressive Lymphoma. ACS applied materials & interfaces 10 (8) (2018)
Prateek Srivastava, Sumit Kumar Hira, Uttam Gupta, Vivek Kumar Singh, Ranjeet Singh, Pankaj Pandey, Divesh Narayan Srivastava, Ram Adhar Singh, Partha Pratim Manna
Pepsin Assisted Doxorubicin Delivery from Mesoporous Silica Nanoparticles Downsizes Solid Tumor Volume and Enhances Therapeutic Efficacy in Experimental Murine Lymphoma. ACS applied bio materials 1 (6) (2018)
Prateek Srivastava, Sumit Kumar Hira, Divesh Narayan Srivastava, Uttam Gupta, Pradip Sen, Ram Adhar Singh, Partha Pratim Manna
Protease-Responsive Targeted Delivery of Doxorubicin from Bilirubin-BSA-Capped Mesoporous Silica Nanoparticles against Colon Cancer. ACS biomaterials science & engineering 3 (12) (2017)
Sharad Kumar Asthana, Ajit Kumar, null Neeraj, null Shweta, Sumit Kumar Hira, Partha Pratim Manna, K K Upadhyay
Brightening Quinolineimines by Al3+ and Subsequent Quenching by PPi/PA in Aqueous Medium: Synthesis, Crystal Structures, Binding Behavior, Theoretical and Cell Imaging Studies. Inorganic chemistry 56 (6) (2017)